## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the
Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma
β Scribed by Melonie A. Nance; Raja R. Seethala; Yun Wang; Simion I. Chiosea; Eugene N. Myers; Jonas T. Johnson; Stephen Y. Lai
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 231 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background We have shown that rILβ2 administration in recurrent head and neck cancers induces a tumorβspecific Tβlymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5βfluorouracil. Longβterm results
Background. Comorbid conditions have a significant impact on the actuarial survival of patients with head and neck cancer. However, no studies have evaluated the impact of comorbidity on tumor-and treatment-specific outcomes. This study was performed to evaluate the impact of comorbidity, graded by
## Background: The authors undertook a retrospective study on local tumor control, survival, and complications of conventional irradiation compared with accelerated hyperfractionated irradiation in women with selected head and neck tumor sites. ## Methods: One hundred eight consecutive women who